Critical

Cholinergic crisis (myasthenia)

Anticholinesterase excess · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Overtreatment with anticholinesterases in myasthenia causes excess acetylcholine - weakness PLUS muscarinic features (salivation, lacrimation, diarrhoea, bradycardia, miosis, fasciculations) - which can mimic a myasthenic crisis but is the opposite problem. Stopping the drug, supporting the airway and atropine for muscarinic effects are key.

Assessment

Investigations

  • Distinguish from myasthenic crisis (cholinergic has muscarinic excess: SLUDGE, miosis, fasciculations)
  • Assess respiratory function (FVC)
  • Review anticholinesterase dosing

Management

  • Stop anticholinesterase medication
  • Support the airway and ventilation (monitor FVC)
  • Atropine for significant muscarinic symptoms/bradycardia
  • Neurology involvement; reassess myasthenia treatment
  • ICU if respiratory failure

Drugs & doses

Stop anticholinesterase
Atropine (muscarinic symptoms)
Ventilatory support

Disposition

Neurology/ICU.

Weakness WITH salivation, diarrhoea, miosis and fasciculations in a myasthenic is cholinergic crisis - stop the pyridostigmine, do not give more.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.